The MBT-fAST clinical studies are planned for the second half of 2024. Bruker also intends concurrent clinical studies for IVDR certification of lipid A-based colistin resistance detection.

1. Bruker introduces fast next-generation MALDI Biotyper IVD Software Microbial identification faster than ever: The MBT Compass HT IVD software provides a high sample throughput for microbial ...

It is ideal for laboratories which are interested in a broad screening approach to detect most pathogens in one run.” To see Bruker’s technology in action, visit booth C3-15 at ECCMID 2023, April ...

It is ideal for laboratories which are interested in a broad screening approach to detect most pathogens in one run.” To see Bruker’s technology in action, visit booth C3-15 at ECCMID 2023, April ...

About the Bruker MALDI Biotyper® (MBT) platform The MBT enables molecular identification of bacteria, yeasts and fungi.

New MBT Compass® HT IVD software provides even higher sample throughput for the MALDI Biotyper as the fastest MALDI system for microbial identification with system time-to-result of ~5 minutes ...

Dr. Diana Kalinina shall introduce the MALDI Biotyper ® sirius platform and elaborate the already available as well as the newly introduced solutions, workflows and accessories that have been made ...